Published

[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2025-05-21
Source: Europe PMC
DOI: 10.1016/j.encep.2025.02.007
PubMed: 40413068

Authors

Dumenil M Cordova G El-Hage W.

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Chronic Pain Receptor Pharmacology Emotional Processing Treatment-Resistant Depression Adverse Events Toxicity Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31 Psilocybin to Manage Cancer-Related DepressionUnknown journal · 2016-12-20 Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-02